Viasys Gets FDA Approval on Sonara
16th Nov 2006, 08:21 GMT
Medical device maker Viasys Healthcare said the FDA approved its blood flow measurement devices Sonara and Sonara/tek.
Viasys Gets FDA Approval on Sonara related news:
- VIASYS NeuroCare Receives 510 Clearance for SONARA and SONARA/tek Digital Transcranial Doppler Systems — FDA News News from StratCenter.com
- VIASYS NeuroCare Inc. Receives 510(K) Clearance for SONARA and SONARA/tek Digital Transcranial Doppler Systems — Nachrichten Ticker - www.finanzen.net
- Diagnosoft Receives FDA Approval for Cardiac MRI Quantitative Regional Function Software Based on the HARP Technology — FDA News News from StratCenter.com
- FDA Allows Resumption of Lupus Trials with Epratuzumab — PR Newswire: All Releases
- FDA Grants Priority Review for Soliris(TM) (eculizumab) BLA for Treatment of Paroxysmal Nocturnal Hemoglobinuria — PR Newswire: All Releases
- FDA Extends Novartis Drug Review — WSJ.com: What's News Europe
- FDA Decision on Novartis Drug Is Delayed — WSJ.com: What's News Europe
- FDA Expands Use of Abbott's Humira — Government/ Industry Regulation News from StratCenter.com
- Viasys buys another sleep-therapy company — bizjournals.com Health Care:Biotechnology headlines
- FDA Review on Novartis Galvus Extended — Government/ Industry Regulation News from StratCenter.com
Latest news from FDA News News from StratCenter.com:
- North American Gets Cancer Treatment OK
- North American Scientific Announces FDA Clearance of its ClearPath HDR Breast Brachytherapy System
- Newly FDA Approved SmartLipo Laser Liposuction Available at the Intimate Rejuvenation and Innovative Surgery Center, Phoenix, AZ.
- ACT-AD Coalition Calls FDA's New Focus on Neurological Diseases a Positive 1st Step
- Ivax Diagnostics Delays Filing 3Q Report
- New Corporate Members and Leaders for C-Path's Predictive Safety Testing Consortium Announced
- Diagnosoft Receives FDA Approval for Cardiac MRI Quantitative Regional Function Software Based on the HARP Technology
- PAREXEL Consulting Expands Risk Mgmt Expertise, Appoints Former FDA Consumer Safety Officer Raymond T Oji as Senior Consultant
- Trubion Pharmaceuticals to Present at the Lazard Life Sciences Conference
- Critical Therapeutics Announces Efficacy Data for Controlled-Release Formulation of Zileuton Presented at ACAAI 2006 Annual Meeting